Survey ApplicationNCT06170502
Developing and Evaluating a Mobil Application AKILMOBIL
A study testing Using the mobile application and applying the survey in people with Survey Application, run by Eskisehir Osmangazi University at 1 site in Turkey (Türkiye).
Trial summary
The research was planned to develop the mobile application (Akil Mobil) that will be designed for parents who continue to use drugs for their children at home after their child is discharged from the hospital and after the discharge education is completed. Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Survey Application
- What is being tested?
- Using the mobile application and applying the survey
- Type of treatment
- Pill or oral medicine, Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 41 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jan 2024to 1 Jan 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Treating the disease condition and being discharged
- Continuing to use medication at home after discharge
- Parents should be able to speak and understand Turkish and be literate.
- Having an Android mobile phone for the mobile application
- Having the video call application on the mobile phone and accepting the video calling application to be made after 1 month
- Voluntary written and verbal informed consent has been obtained from the parents.
Who cannot join
- Parents' unwillingness to continue working at any stage of the research
- Termination of drug use due to the termination of their children's treatment
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Aysegul
Ankara, Mamak, 06100
ayşegül karaca, 05337691532, aysegulkaraca_88@hotmail.com
About this study
Official title: Developing and Evaluating a Mobil Application for Rational Drug Use in Parents of Pediatric Patients After Discharge (Akilmobil)
The research was planned to develop the mobile application (Akil Mobil) that will be designed for parents who continue to use drugs for their children at home after their child is discharged from the hospital and after the discharge education is completed. The type of study is a randomized controlled experimental study.
Read the detailed description
The irrational use of drugs is a major problem all over the world. About half of the patients cannot use the drugs correctly. Over, under or misuse of drugs leads to waste of resources and poor health conditions. The patients and their relatives who manage the use of drugs at home are most important componenets in this regard. Administration of the medication at home to the children mostly lead by parents.
Despite being informed during discharge, parents can make many mistakes in adjusting the dosage, preparing and administering tablet, capsule, suspension forms of drugs. And there are difficulties in accessing reliable sources of information.
It is necessary to keep the knowledge and skills of the parents of children with chronic diseases, who uses drugs for a long time, up-to-date. Therefore, continuous and accessible training and support systems are needed. Recently, mobile applications that can be easily accessed from mobile phones have become widespread thanks to technological developments. Regardless of their socioeconomic level, anyone with a smartphone can use these applications. A mobile application with home drug preparation and application can provide information and support for parents in the preparation and administration of appropriate doses.
For this reason, the aim of this project is to develop and evaluate a mobile application (AkilMobil) that prevents parents who continue to use drugs for their children at home after their child is discharged from the hospital. The research is a randomized controlled experimental study. In the study, "Education Needs of Parents who Administering Medicines at Home Form", "Descriptive Information Form", "Parental Drug Preparation Information Evaluation Form", " Suspension Drug Administration Parent Evaluation Form", "Capsule Drug Administration Parent Evaluation Form", "Tablet Drug Administration Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" developed by the researchers in line with the literature, and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used.
In the application, there will be drug information, indications, effects, side effects, preparation and administration methods, instructions for use, drug interaction information, dose calculation and drug preparation videos of drugs that are frequently used in chronic diseases, which are understood by parents. Interaction with users will be provided with frequently asked questions and the opportunity to ask researchers directly. With this application, parents can prevent dose errors due to lack of information while preparing drugs at home and information pollution due to applying to incorrect and insufficient sources. The mobile application's ease of access, presentation of visual resources and providing understandable information are the original values of our work. It is a technological advance for rational drug use and quality health care.
- Conditions
- Survey Application
- Being tested
- Using the mobile application and applying the survey
- Keywords
- drug, nurse, rational medicine
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Using the mobile application and applying the surveyDevice
In the study, "The Form for Determining the Educational Needs of Parents Administering Medicines at Home", "Introductory Information Form", "Parental Drug Preparation Information Evaluation Form", "Parent Evaluation Form in Suspension Drug Administration", "Capsule Drug Application Parent Evaluation Form", developed by the researchers in line with the literature, "Tablet Pharmaceutical Application Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used.
| Study group | Role | What they receive |
|---|---|---|
| mobile application development and implementation | Experimental | The aim of the project is to develop and evaluate the effectiveness of a mobile application (AkilMobil) that prevents parents who continue to use drugs for their children at home after their child is discharged from the hospital. The research is a randomized controlled experimental study. In the study, "The Form for Determining the Educational Needs of Parents Administering Medicines at Home", "Introductory Information Form", "Parental Drug Preparation Information Evaluation Form", "Parent Evaluation Form in Suspension Drug Administration", "Capsule Drug Application Parent Evaluation Form", developed by the researchers in line with the literature, "Tablet Pharmaceutical Application Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used. Receives: Device: Using the mobile application and applying the survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mobile Application Usability Survey
Mothers with children with chronic diseases were evaluated with a mobile application usability survey, change in medication preparation activities in the 3rd month.
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Dec 2023
- Study start1 Jan 2024 (estimated)
- Primary completion1 Jan 2025 (estimated)
- Study completion1 Jan 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Survey ApplicationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- The type of study is a randomized controlled experimental study. In the research, it is aimed to evaluate the effectiveness of the mobile application (Akil Mobil).
- Masking
- None (open label)
- Enrolment
- 41 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Eskisehir Osmangazi University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ayşegül Karaca, Eskisehir Osmangazi University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06170502
- Sponsor's protocol ID
- TUBITAK 2023
- Status last verified
- Dec 2023
- First submitted
- 1 Sep 2023
- Last updated
- 14 Dec 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: due to the development
Study at a glance
From the registry record, last updated by the sponsor on 14 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Developing and Evaluating a Mobil Application for Rational Drug Use in Parents of Pediatric Patients After Discharge (Akilmobil)
- ClinicalTrials.gov ID
- NCT06170502
- Acronym / sponsor ID
- TUBITAK 2023
- Conditions
- Survey Application
- Keywords
- drug, nurse, rational medicine
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 41 participants (estimated)
- Lead sponsor
- Eskisehir Osmangazi UniversityUniversity, hospital or other
- Study start
- 1 Jan 2024 (estimated)
- Primary completion
- 1 Jan 2025 (estimated)
- Study completion
- 1 Jan 2025 (estimated)
- First posted
- 14 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The research was planned to develop the mobile application (Akil Mobil) that will be designed for parents who continue to use drugs for their children at home after their child is discharged from the hospital and after the discharge education is completed. The type of study is a randomized controlled experimental study.
Detailed description
The irrational use of drugs is a major problem all over the world. About half of the patients cannot use the drugs correctly. Over, under or misuse of drugs leads to waste of resources and poor health conditions. The patients and their relatives who manage the use of drugs at home are most important componenets in this regard. Administration of the medication at home to the children mostly lead by parents.
Despite being informed during discharge, parents can make many mistakes in adjusting the dosage, preparing and administering tablet, capsule, suspension forms of drugs. And there are difficulties in accessing reliable sources of information.
It is necessary to keep the knowledge and skills of the parents of children with chronic diseases, who uses drugs for a long time, up-to-date. Therefore, continuous and accessible training and support systems are needed. Recently, mobile applications that can be easily accessed from mobile phones have become widespread thanks to technological developments. Regardless of their socioeconomic level, anyone with a smartphone can use these applications. A mobile application with home drug preparation and application can provide information and support for parents in the preparation and administration of appropriate doses.
For this reason, the aim of this project is to develop and evaluate a mobile application (AkilMobil) that prevents parents who continue to use drugs for their children at home after their child is discharged from the hospital. The research is a randomized controlled experimental study. In the study, "Education Needs of Parents who Administering Medicines at Home Form", "Descriptive Information Form", "Parental Drug Preparation Information Evaluation Form", " Suspension Drug Administration Parent Evaluation Form", "Capsule Drug Administration Parent Evaluation Form", "Tablet Drug Administration Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" developed by the researchers in line with the literature, and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used.
In the application, there will be drug information, indications, effects, side effects, preparation and administration methods, instructions for use, drug interaction information, dose calculation and drug preparation videos of drugs that are frequently used in chronic diseases, which are understood by parents. Interaction with users will be provided with frequently asked questions and the opportunity to ask researchers directly. With this application, parents can prevent dose errors due to lack of information while preparing drugs at home and information pollution due to applying to incorrect and insufficient sources. The mobile application's ease of access, presentation of visual resources and providing understandable information are the original values of our work. It is a technological advance for rational drug use and quality health care.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- The type of study is a randomized controlled experimental study. In the research, it is aimed to evaluate the effectiveness of the mobile application (Akil Mobil).
| Arm | Type | Receives |
|---|---|---|
| mobile application development and implementation | Experimental | Device: Using the mobile application and applying the surveyThe aim of the project is to develop and evaluate the effectiveness of a mobile application (AkilMobil) that prevents parents who continue to use drugs for their children at home after their child is discharged from the hospital. The research is a randomized controlled experimental study. In the study, "The Form for Determining the Educational Needs of Parents Administering Medicines at Home", "Introductory Information Form", "Parental Drug Preparation Information Evaluation Form", "Parent Evaluation Form in Suspension Drug Administration", "Capsule Drug Application Parent Evaluation Form", developed by the researchers in line with the literature, "Tablet Pharmaceutical Application Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used. |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (6 listed)
- Treating the disease condition and being discharged
- Continuing to use medication at home after discharge
- Parents should be able to speak and understand Turkish and be literate.
- Having an Android mobile phone for the mobile application
- Having the video call application on the mobile phone and accepting the video calling application to be made after 1 month
Key exclusion criteria (2 listed)
- Parents' unwillingness to continue working at any stage of the research
- Termination of drug use due to the termination of their children's treatment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Using the mobile application and applying the surveyIn the study, "The Form for Determining the Educational Needs of Parents Administering Medicines at Home", "Introductory Information Form", "Parental Drug Preparation Information Evaluation Form", "Parent Evaluation Form in Suspension Drug Administration", "Capsule Drug Application Parent Evaluation Form", developed by the researchers in line with the literature, "Tablet Pharmaceutical Application Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used. | Device | mobile application development and implementation |
Primary outcome
Mobile Application Usability Survey
Time frame: 3 months
Mothers with children with chronic diseases were evaluated with a mobile application usability survey, change in medication preparation activities in the 3rd month.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Dec 2023.
- Individual participant dataSharing planned: No. due to the development
Related trials for Survey Application
Recruiting
Feasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study
Caregivers
RecruitingObservational study
Addressing Pregnant Women's First Trimester Worries and Information Needs With mHealth Solutions
Pregnancy Trimester, First, Anxiety
RecruitingObservational study
GCP-R3 Clinical Practice Survey in Research Centers
Clinical Research
Enrolling by invitationObservational study
Manual Therapy Behavior Scale in Physiotherapists
Attitude of Health Personnel
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Using the mobile application and applying the survey in people with Survey Application, run by Eskisehir Osmangazi University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ayşegül Karaca (05337691532, aysegulkara_88@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mobile Application Usability Survey (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2023.